Key facts
- It has raised $1.0M; the latest was Early Stage VC ($1.0M) in Jul 2025.
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for AurisOne
- ·The full record, as it builds
Funding rounds
No funding rounds for AurisOne are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About AurisOne
Developer of a generative AI-powered healthcare platform designed for automating medical reporting workflows. The company's platform listens to doctor-patient conversations, transcribes dictation, interprets uploaded medical documents, and compiles structured visit records with editable notes using ambient clinical intelligence and multilingual speech recognition, enabling healthcare providers and small to mid-sized medical practitioners to reduce administrative workload, improve physician satisfaction, and enhance the quality of patient care.
- Sector
- Healthcare
- HQ
- Prague, Czech Republic
- Founded
- 2024
- Website
- aurisone.com/
- Ownership
- Privately Held (backing)
AurisOne doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in AurisOne shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on AurisOne in its N-PORT filings yet. We sweep new filings monthly.